Literature DB >> 25520447

Hepatitis C virus genotype 7, a new genotype originating from central Africa.

Donald G Murphy1, Erwin Sablon2, Jasmine Chamberland3, Eric Fournier3, Raymond Dandavino4, Cécile L Tremblay3.   

Abstract

We report a new hepatitis C virus (HCV) genotype identified in patients originating from the Democratic Republic of Congo. The prototype QC69 virus is shown to be a new lineage distinct from genotypes 1 to 6. Three additional patients were also found to be infected by a virus from this lineage, confirming its circulation in humans. We propose that these viruses be classified into HCV genotype 7.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25520447      PMCID： PMC4390628          DOI： 10.1128/JCM.02831-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region.

Authors:  Tatsunori Nakano; Gillian M G Lau; Grace M L Lau; Masaya Sugiyama; Masashi Mizokami
Journal:  Liver Int       Date:  2011-12-05       Impact factor: 5.828

Review 2.  Unravelling hepatitis C virus replication from genome to function.

Authors:  Brett D Lindenbach; Charles M Rice
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

3.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

4.  The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960.

Authors:  Richard Njouom; Eric Nerrienet; Martine Dubois; Guillaume Lachenal; Dominique Rousset; Aurelia Vessière; Ahidjo Ayouba; Christophe Pasquier; Régis Pouillot
Journal:  Infect Genet Evol       Date:  2006-11-29       Impact factor: 3.342

5.  Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

Authors:  Judith M Gottwein; Troels K H Scheel; Tanja B Jensen; Jacob B Lademann; Jannick C Prentoe; Maria L Knudsen; Anne M Hoegh; Jens Bukh
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

6.  Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor.

Authors:  Judith M Gottwein; Sanne B Jensen; Stéphanie B N Serre; Lubna Ghanem; Troels K H Scheel; Tanja B Jensen; Henrik Krarup; Nathalie Uzcategui; Lotte S Mikkelsen; Jens Bukh
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

7.  Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay.

Authors:  Françoise Bouchardeau; Jean François Cantaloube; Stéphane Chevaliez; Christine Portal; Annie Razer; Jean-Jacques Lefrère; Jean Michel Pawlotsky; Philippe De Micco; Syria Laperche
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

8.  Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.

Authors:  Troels K H Scheel; Jannick Prentoe; Thomas H R Carlsen; Lotte S Mikkelsen; Judith M Gottwein; Jens Bukh
Journal:  PLoS Pathog       Date:  2012-05-24       Impact factor: 6.823

9.  Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource.

Authors:  Donald B Smith; Jens Bukh; Carla Kuiken; A Scott Muerhoff; Charles M Rice; Jack T Stapleton; Peter Simmonds
Journal:  Hepatology       Date:  2014-01       Impact factor: 17.425

10.  Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa.

Authors:  Peter V Markov; Jacques Pepin; Eric Frost; Sylvie Deslandes; Annie-Claude Labbé; Oliver G Pybus
Journal:  J Gen Virol       Date:  2009-05-27       Impact factor: 3.891
View more
  49 in total

1.  Genetic Diversity of Hepatitis C Virus Among Blood Donors and Patients with Clinical Hepatitis in Ibadan, Nigeria.

Authors:  J A Shenge; G N Odaibo; D O Olaleye
Journal:  Arch Basic Appl Med       Date:  2018-02

2.  The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymerase.

Authors:  Kyle J Eastman; Kyle Parcella; Kap-Sun Yeung; Katharine A Grant-Young; Juliang Zhu; Tao Wang; Zhongxing Zhang; Zhiwei Yin; Brett R Beno; Steven Sheriff; Kevin Kish; Jeffrey Tredup; Adam G Jardel; Vivek Halan; Kaushik Ghosh; Dawn Parker; Kathy Mosure; Hua Fang; Ying-Kai Wang; Julie Lemm; Xiaoliang Zhuo; Umesh Hanumegowda; Karen Rigat; Maria Donoso; Maria Tuttle; Tatyana Zvyaga; Zuzana Haarhoff; Nicholas A Meanwell; Matthew G Soars; Susan B Roberts; John F Kadow
Journal:  Medchemcomm       Date:  2017-02-08       Impact factor: 3.597

3.  Exploring small molecules with pan-genotypic inhibitory activities against hepatitis C virus NS3/4A serine protease.

Authors:  Jinhong Ren; Isabel Ojeda; Maulik Patel; Michael E Johnson; Hyun Lee
Journal:  Bioorg Med Chem Lett       Date:  2019-06-08       Impact factor: 2.823

4.  An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots.

Authors:  Jonathan B Parr; Evans K Lodge; Vera Holzmayer; Jacques Pepin; Eric H Frost; Michael W Fried; David R McGivern; Stanley M Lemon; Corinna Keeler; Michael Emch; Kashamuka Mwandagalirwa; Antoinette Tshefu; Franck Fwamba; Jérémie Muwonga; Steven R Meshnick; Gavin Cloherty
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

5.  Improving Metabolic Stability with Deuterium: The Discovery of BMT-052, a Pan-genotypic HCV NS5B Polymerase Inhibitor.

Authors:  Kyle Parcella; Kyle Eastman; Kap-Sun Yeung; Katharine A Grant-Young; Juliang Zhu; Tao Wang; Zhongxing Zhang; Zhiwei Yin; Dawn Parker; Kathy Mosure; Hua Fang; Ying-Kai Wang; Julie Lemm; Xiaoliang Zhuo; Umesh Hanumegowda; Mengping Liu; Karen Rigat; Maria Donoso; Maria Tuttle; Tatyana Zvyaga; Zuzana Haarhoff; Nicholas A Meanwell; Matthew G Soars; Susan B Roberts; John F Kadow
Journal:  ACS Med Chem Lett       Date:  2017-06-29       Impact factor: 4.345

6.  Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening.

Authors:  Jennifer M Pfaff-Kilgore; Edgar Davidson; Kathryn Kadash-Edmondson; Mayda Hernandez; Erin Rosenberg; Ross Chambers; Matteo Castelli; Nicola Clementi; Nicasio Mancini; Justin R Bailey; James E Crowe; Mansun Law; Benjamin J Doranz
Journal:  Cell Rep       Date:  2022-05-24       Impact factor: 9.995

Review 7.  Direct-Acting Antiviral Agents for Hepatitis C Virus Infection-From Drug Discovery to Successful Implementation in Clinical Practice.

Authors:  Christopher Dietz; Benjamin Maasoumy
Journal:  Viruses       Date:  2022-06-17       Impact factor: 5.818

Review 8.  Hepatitis C Virus Infection in Chronic Kidney Disease.

Authors:  Marco Ladino; Fernando Pedraza; David Roth
Journal:  J Am Soc Nephrol       Date:  2016-04-19       Impact factor: 10.121

9.  Comparison of Three Different Hepatitis C Virus Genotyping Methods: 5'NCR PCR-RFLP, Core Type-Specific PCR, and NS5b Sequencing in a Tertiary Care Hospital in South India.

Authors:  Hubert D-J Daniel; Joel David; Sukanya Raghuraman; Manu Gnanamony; George M Chandy; Gopalan Sridharan; Priya Abraham
Journal:  J Clin Lab Anal       Date:  2016-09-01       Impact factor: 2.352

Review 10.  A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis.

Authors:  Corey Saraceni; John Birk
Journal:  J Clin Transl Hepatol       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.